Biogen Inc

BIIB:NASDAQ
RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:42 PM EST
271.00quote price arrow up+0.72 (+0.27%)
Volume
40,460
Close
270.28quote price arrow down-3.56 (-1.30%)
Volume
1,252,175
52 week range
223.25 - 374.99

...

Loading . . .

KEY STATS

  • Open274.31
  • Day High274.54
  • Day Low267.67
  • Prev Close273.84
  • 52 Week High374.99
  • 52 Week High Date02/05/20
  • 52 Week Low223.25
  • 52 Week Low Date11/09/20
  • Market Cap41,590.69M
  • Shares Out153.88M
  • 10 Day Average Volume1.41M
  • Dividend-
  • Dividend Yield-
  • Beta0.49
  • 1 Year % Change-5.33

RATIOS/PROFITABILITY

  • EPS (TTM)30.21
  • P/E (TTM)8.95
  • Fwd P/E (NTM)11.65
  • EBITDA (MRQ)7,426.60M
  • ROE (MRQ)41.06%
  • Revenue (MRQ)14,263.30M
  • Gross Margin (MRQ)87.65%
  • Net Margin (MRQ)36.23%
  • Debt To Equity (MRQ)69.02%

EVENTS

  • Earnings Date02/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Biogen Inc News

There is no recent news for this security.

Latest BIIB News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Biogen Inc. is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). It also has a collaboration...
Stelios Papadopoulos Ph.D.
Chairman
Michel Vounatsos
Chief Executive Officer
Michael McDonnell
Chief Financial Officer
Robin Kramer
Chief Accounting Officer
Susan Alexander Esq.
Executive Vice President
Address
225 Binney St
Cambridge, MA
02142-1031
United States